前列腺癌是男性常见的恶性肿瘤,近年来我国发病率有所增长,并且约50％病人作出诊断时已有转移。除传统的睾丸切除,雌激素治疗外,近年来又发展了多种抑制雄激素合成,抗雄激素,抗雌激素治剂,尤其合成了黄体生素释放激素类似物,临床上取得极好效果,使晚期前列腺癌病人解除痛苦,延长寿命。 Prostate cancer is a common malignancy in males. The incidence in China has increased in recent years, and about 50% of patients have metastasized when they make a diagnosis. In addition to the traditional testicular resection and estrogen therapy, in recent years, a number of inhibitors of androgen synthesis, antiandrogens, and anti-estrogen agents have been developed. In particular, luteinizing hormone-releasing hormone analogues have been synthesized, and clinically excellent results have been achieved. To relieve the pain of patients with advanced prostate cancer and prolong their life span.